SUMMARY This paper presents the clinical and pathological findings in 40 consecutive patients seen with primary tumours arising from the lacrimal gland. Twenty patients had a benign mixedcell tumour. They presented in a recognisable clinical manner with a painless mass in the region of the lacrimal gland which slowly enlarged over a period of at least 1 year before consultation.
This communication presents an analysis of the mode of clinical presentation of a large series of lacrimal gland tumours. The correct management of lacrimal fossa lesions depends on recognising the characteristic clinical presentation of benign mixed cell tumours so that a biopsy is avoided and the capsule of the tumour remains intact. Excision of the whole of the lacrimal gland together with the tumour avoids any risk of seeding tumour cells into the adjacent tissues with the possibility of a recurrence with malignant potential (Rubin, 1947; Zimmerman et al., 1962; Waller et al., 1973) .
All other lesions in this region, apart from acute dacryoadenitis and dermoid cysts, require incisional biopsy through an anterior approach so that a definitive histological diagnosis can be made. After such a biopsy histological as well as clinical criteria can be used to decide which type of treatment is most appropriate.
Material and methods
Clinical records and histopathological findings of 108 in an attempt to identify clinical characteristics that would allow recognition of benign mixed lacrimal gland tumours from other lesions of the superotemporal orbit. There were 40 cases of benign or malignant epithelial lacrimal gland tumours. All had plain radiographs and a histological diagnosis. The other cases were nonepithelial lesions such as acute and chronic nongranulomatous inflammation, granulomatous inflammation, ideopathic inflammatory pseudotumour, lymphoma, and dermoid cysts. Orbital involvement in some of these cases was not confined to the lacrimal fossa.
Evaluation of patients presenting with lacrimal gland fossa symptoms and signs included a general medical examination, blood studies, and plain and tomographic radiographs of the orbits. Orbital ultrasonography and computerised tomography were performed in selected cases.
Results
Twenty patients in the series had benign mixed lacrimal gland tumours. They comprised 11 men and 9 women, with an age range of 21-68 years (Table 1 (Fig. 1) . A careful detailed history will reveal that the duration of symptoms is more than 12 months. Radiographs usually show enlargement of the lacrimal fossa without invasion of overlying bone ( Fig. 2) (Jones and Pfeiffer, 1954; Newton, 1962; Lloyd, 1975) . Careful tomographic study may disclose this characteristic change when (Fig. 3) . Although the clinical presentation of cases of benign mixed lacrimal gland tumours has been described in a number of excellent reviews (Forrest, 1954; Davies, 1954; Reese, 1956; Zimmerman et al., 1962; Henderson, 1973) (Fig. 5) . In all such patients it is important that both axial and coronal tomograms are obtained so that the structure of the bones in relation to the tumour can be examined in some detail. This type of assessment has now been supplemented by coronal and axial CT scans. Inflammatory pseudotumours in the region of the lacrimal gland are relatively common. Although they are rare in the very young, the age variation is wide (Chavis et al., 1978) . Most commonly the signs and symptoms are similar to those seen in acute dacryoadenitis, though the patient is apyrexial with a normal white cell count. Some patients have a slowly enlarging mass which may not be tender, though the pain is frequently noticed. Plain radiographs are invariably normal, and CT scans will demonstrate the size and extent of the mass. Ultrasonic scans can provide useful information, the pattern of echoes placing the tumour in the lymphoma-pseudotumour group.
Lymphomatous lesions include a broad spectrum from reactive lymphoid hyperplasia to malignant lymphomas of various types. They most commonly occur in adults with a progressive swelling of the eyelid over a period of several months. Inflammatory signs and symptoms are extremely uncommon. A firm nontender mass can usually be palpated in the region of the lacrimal gland. The presence of a purple pink fleshy lesion underneath the conjunctiva of the upper fornix is characteristic of this lesion. The importance of recognising the first group on clinical grounds cannot be emphasised too often. The temptation to biopsy the lesion should be avoided, and total removal of the whole of the lacrimal gland through a lateral orbitotomy can be planned. The choice of approach to the gland is of prime importance, for the exposure should be such that the palpebral lobe and the structures of the eyelid can be dissected out under an operating microscope. It is essential that in removing the lacrimal gland plus tumour the capsule of the tumour is not touched and that periosteum overlying the tumour is removed at the same time. The modified lateral orbitotomy approach offers the only way to achieve the correct and adequate removal of the tumour. A transcranial anterior orbitotomy or the Berke lateral orbitotomy makes it extremely difficult or impossible to avoid a subtotal or piecemeal removal of the gland and tumour.
Rupture of the capsule of a benign mixed cell tumour affects the prognosis adversely because of seeding of the tumour cells into the surrounding tissues. Recurrences are thus inevitable, and in many cases, although such recurrences are histologically nonmalignant, malignant changes can occur. In patients in whom the recurrences remain benign the outcome is often indistinguishable from that seen in a true carcinoma. The tumour cells invade the apex of the orbit and the surrounding bone. A painful and lingering death ensues, for in most cases the tumour spreads beyond the line of surgical resection, and, although radiotherapy may be used as a palliative measure, benign mixed cell tumours are relatively radioresistant.
Patients with a very short history of a lacrimal fossa swelling and associated inflammatory signs can reasonably be treated with a short course of antibiotics. Resolution within 2 to 3 weeks would be the expected course. Unless the mass shows a progressive decrease in size, early incisional biopsy should be done. Patients with a history of a few months' swelling in the region of the lacrimal gland with or without inflammatory signs or abnormal x-rays should be biopsied forthwith.
One other group of patients can be identified in whom an early biopsy is indicated. These are patients who have a history of longer than 12 months but do not fit into the clinical pattern presented by the benign mixed cell tumours. They often complain of pain and show radiological evidence of invasion of the overlying bone or evidence of calcification within the tumour. A biopsy should be obtained in all these cases through a transseptal incision. The extraperiosteal approach should never be used, for the integrity of the periosteal barrier must be maintained to prevent possible seeding of the extraperiosteal space by malignant cells. By following this regimen a definite diagnosis will be reached at an early stage in the clinical evaluation. Such diverse lesions as inflammatory masses, lymphomas, and carcinomas will be accurately identified and the appropriate treatment started.
Patients found to have adenoid cystic carcinomas and other malignant epithelial neoplasms should be evaluated to determine the extent of the tumour. Where there is evidence of restriction of the tumour mass within the periosteal barrier and without involvement of the orbital apex, a radical resection of the area can be undertaken. The skills of a neurosurgeon and plastic surgeon as well as the of ophthalmic surgeon should be united in such a surgical operation. Surgical resection in these cases should include portions of the lateral and superior orbital walls as well as removal of the lids and orbital contents. A report describing the criteria of operability, recommended surgical approaches, and the results of the experience with malignant lacrimal gland neoplasms at Moorfields Eye Hospital is in 604 group.bmj.com on October 14, 2017 -Published by http://bjo.bmj.com/ Downloaded from Clinical preseintationi anid matnagemenit of lacrimal glaiid titmoiars *Characteristic presentation of benign mixed cell lacrimal gland tumouir.
preparation. Radiotherapy and chemotherapy may be considered in those cases in which spread has occurred beyond even these wide surgical margins. The outlook for these patients is extremely poor (Forrest, 1954; Zimmerman et al., 1962; Forrest, 1971; Henderson, 1973; Ashton, 1975) . This approach, graphically summarised in Table  2 , diminishes the need for histological diagnosis by frozen section and permits decisions on extensive surgical removal of a neoplastic lesion to be based on evaluation of permanent appropriately fixed and stained microscopic sections. Furthermore, the risks of incisional biopsy of a benign mixed tumour and its subsequent potential recurrence are minimised. This risk cannot be completely eliminated, for occasionally a patient with a benign mixed-cell tumour arising in the palpebral lobe will present with a short history of a slowly enlarging mass similar to a chalazion, and in these circumstances invariably the lesion is approached directly.
No protocol can provide foolproof solutions to the complex decisions facing the surgeon. Nonetheless, this diagnostic approach based primarily on clinical history and radiographic findings, does provide a logical approach to the problem of lacrimal gland and fossa lesions. In part the dismal prognosis of malignant lacrimal gland tumours is related to delay in diagnosis, with subsequent spread beyond the limits of surgical excision. We think that an improved survival rate can be achieved by an aggressive attitude towards early biopsy followed by extirpative surgery.
